- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03212079
Physical Activities by Technology Help (PATH) (PATH)
Novel Individualized Intervention for Behavioral Change Among High-Risk Group Cancer Survivors : Physical Activities by Technology Help (PATH)
Study Overview
Status
Intervention / Treatment
Detailed Description
If the participant agree to be in this study, the investigators will ask the participant to do the following things:
The participant will be asked questions about his/her physical activity (walking, running or other exercise) to determine if he/she are eligible to participate. If the participant is eligible and interested in participating, the investigators will ask hi/her to read and sign the consent form.
After that, the investigators will randomly assign the participant to a research group (this method would be similar to drawing numbers from a hat). The result will determine which group the participant will belong to. The study would have three different groups:
- Group one will be self-motivated to be physically active (control group)
- The second group will receive smart daily text messages only (text group);
The last group would have the Amazon Echo smart device installed in participants' homes and they will interact with a digital voice assist that will help them be active (Alexa group).
- All study participants will receive a Fitbit device which you can keep after the study.
- When the investigators start the study, the participant will be asked to start wearing wrist device immediately. For the next one week the investigators will monitor the participant daily number of steps to establish how active he/she is. The participant will not be required to change his/her daily routine in the first week.
- After the end of the first week, the investigators will ask the participant to increase his/her daily steps to at least 10 thousand steps per day for the next four weeks. In total the participant will have one week of hi/her normal daily routine and four weeks of trying to do 10 thousand steps per day or more.
- If the participant is in the control group, the investigators will ask you to try to do 10 thousand steps per day on his/her own.
- If the participant are in the text group, he/she will get smart text messages with healthy tips to help track his/her activities and reach his/her daily goal.
- If the participant is in Alexa group, a study member will visit the participant at his/her home before the end of the first week to install the Echo smart speaker and to explain to the participant how to use the voice assist to help him/her become more active for the next four weeks.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Maryland
-
Baltimore, Maryland, United States, 21205
- Johns Hopkins Bloomberg School of Public Health
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- A cancer survivor of breast, prostate, lung, colorectal, cervical or oral cancer survivor and live within the Baltimore Maryland area.
- Finished your active cancer treatment at least three months ago.
- Overweight or obese and do not exercise daily.
- Do not have any physical limitation to do mild to moderate physical activities.
- Have a smart phone (iPhone or Android device) with Wi-Fi internet connection at home.
- Actively using an email account
- Willing to accept the random study assignment.
- Willing to wear a Fitbit band 'a physical activity tracking device' on your wrist for five weeks every single day.
- Willing to have an Echo speaker 'a smart home speaker with voice assistant' installed in your home and use the digital voice assist for four weeks.
- Willing to receive daily text messages on your phone for four weeks.
- Willing to provide us with access to your Fitbit physical activities data.
- Willing to sign the consent form.
Exclusion Criteria:
- Already doing moderate to high physical activities in their daily life (rapid screener).
- Planning to relocate within the next 4-5 weeks.
- Stage 4 cancer.
- Already using physical activity tracker or part of a physical activity program.
- Part of another study that may interfere with our outcome of interest, unstable mental condition.
- Mental condition that prevents patient from performing the study activities and requirements.
- Pregnancy.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Control
The participant will self motivate hi/herself to increase physical activities.
|
|
Experimental: Mycoach Smart Text
The participant will receive personalized smart text messages to encourage him/her to increase physical activities
|
Personalized text messages to you cellphone to help you become more active
Other Names:
|
Experimental: MyCoach via Amazon Alexa
The participant will interact with intelligent coach on Amazon Alexa (a digital voice assist) to help him/her become more active
|
This is an intelligent voice that you can communicate with via Amazon echo speaker
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Average number of steps. Wearable sensor based
Time Frame: 5 weeks
|
The investigators will measure your physical activity by number of steps before and after intervention via wearable activity tracker.
|
5 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Total number and duration of activity bouts. Wearable sensor based
Time Frame: 5 weeks
|
Defined as 3 min.
or more of uninterrupted activity measured by wearable sensor.
|
5 weeks
|
Transitions between active/inactive periods. Wearable sensor based
Time Frame: 5 weeks
|
Time spent walking vs time spent sitting measured by all in one sensor.
|
5 weeks
|
Daily patterns of activity. Wearable sensor based
Time Frame: 5 weeks
|
Distribution parameter of number of steps per/minute within 24 hours period.
Measured by all in one sensor.
|
5 weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Ahmed Hassoon, MD,MPH,PMP, Johns Hopkins Bloomberg School of Public Health
Publications and helpful links
General Publications
- Hassoon A, Baig Y, Naiman DQ, Celentano DD, Lansey D, Stearns V, Coresh J, Schrack J, Martin SS, Yeh HC, Zeilberger H, Appel LJ. Randomized trial of two artificial intelligence coaching interventions to increase physical activity in cancer survivors. NPJ Digit Med. 2021 Dec 9;4(1):168. doi: 10.1038/s41746-021-00539-9.
- Hassoon A, Schrack J, Naiman D, Lansey D, Baig Y, Stearns V, Celentano D, Martin S, Appel L. Increasing Physical Activity Amongst Overweight and Obese Cancer Survivors Using an Alexa-Based Intelligent Agent for Patient Coaching: Protocol for the Physical Activity by Technology Help (PATH) Trial. JMIR Res Protoc. 2018 Feb 12;7(2):e27. doi: 10.2196/resprot.9096.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB00113882
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cervical Cancer
-
University of California, San DiegoWithdrawnCervical Cancer | Cervical Cancer Stage | Cervical Cancer Stage IB2 | Cervical Cancer Stage IB1 | Cervical Cancer Stage I | Cervical Cancer Stage IB | Cervical Cancer Stage II | Cervical Cancer Stage IIa | Cervical Cancer, Stage IIB | Cervical Cancer, Stage III | Cervical Cancer Stage IIIB | Cervical Cancer... and other conditionsUnited States
-
M.D. Anderson Cancer CenterWithdrawnStage IB3 Cervical Cancer FIGO 2018 | Stage II Cervical Cancer FIGO 2018 | Stage IIA Cervical Cancer FIGO 2018 | Stage IIA1 Cervical Cancer FIGO 2018 | Stage IIA2 Cervical Cancer FIGO 2018 | Stage IIB Cervical Cancer FIGO 2018 | Stage III Cervical Cancer FIGO 2018 | Stage IIIA Cervical Cancer FIGO... and other conditions
-
Abramson Cancer Center of the University of PennsylvaniaWithdrawnCervical Cancer | Stage IB Cervical Cancer | Stage IIA Cervical Cancer | Stage IIB Cervical Cancer | Stage III Cervical Cancer | Stage IVA Cervical Cancer
-
National Cancer Institute (NCI)CompletedCervical Adenocarcinoma | Cervical Squamous Cell Carcinoma | Stage IB Cervical Cancer | Stage IIA Cervical Cancer | Stage IIB Cervical Cancer | Stage III Cervical Cancer | Stage IVA Cervical Cancer | Stage IVB Cervical CancerUnited States
-
Mayo ClinicNational Cancer Institute (NCI)RecruitingCervical Adenosquamous Carcinoma | Cervical Squamous Cell Carcinoma, Not Otherwise Specified | Recurrent Cervical Carcinoma | Stage IB3 Cervical Cancer FIGO 2018 | Stage II Cervical Cancer FIGO 2018 | Stage IIA Cervical Cancer FIGO 2018 | Stage IIA1 Cervical Cancer FIGO 2018 | Stage IIA2 Cervical... and other conditionsUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingStage IA Cervical Cancer | Stage IB Cervical Cancer | Stage IA1 Cervical Cancer | Stage IA2 Cervical Cancer | Stage IB1 Cervical Cancer | Stage IB2 Cervical Cancer | Stage IB3 Cervical CancerUnited States
-
Shanghai First Maternity and Infant HospitalNot yet recruitingCervical Cancer, Stage IIB | Cervical Cancer Stage IIIB | Cervical Cancer Stage IIIA | Cervical Cancer, Stage IVA
-
University of Southern CaliforniaNational Cancer Institute (NCI)CompletedRecurrent Cervical Cancer | Stage IVA Cervical Cancer | Stage IVB Cervical Cancer | Stage IIIA Cervical Cancer | Stage IIIB Cervical CancerUnited States
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedCervical Adenocarcinoma | Cervical Squamous Cell Carcinoma | Stage IB Cervical Cancer | Stage IIA Cervical Cancer | Stage IIB Cervical Cancer | Stage III Cervical Cancer | Stage IVA Cervical CancerUnited States
-
Institut de Cancérologie de LorraineCompletedCervical Adenocarcinoma | Stage IB Cervical Cancer | Stage III Cervical Cancer | Stage II Cervical CancerFrance
Clinical Trials on Mycoach Smart Text
-
University of Wisconsin, MadisonNational Heart, Lung, and Blood Institute (NHLBI)RecruitingChronic Conditions, MultipleUnited States
-
Johns Hopkins UniversityCompleted
-
Johns Hopkins UniversityNational Institute of Allergy and Infectious Diseases (NIAID)Completed
-
Walter Reed National Military Medical CenterUniformed Services University of the Health SciencesUnknownSubthreshold PTSDUnited States
-
Inje UniversityCompletedBRONCHIAL ASTHMAKorea, Republic of
-
Medical University of South CarolinaBoston Scientific CorporationRecruitingSubcutaneous ICD | Myopotential InterferenceUnited States
-
Massachusetts General HospitalElizabeth Dole FoundationCompleted
-
University of Illinois at Urbana-ChampaignCompleted
-
Lawson Health Research InstituteNot yet recruitingPTSD | Post-traumatic Stress DisorderCanada